Anaeropharma and Chugai partner to discover cancer drugs using anaerobic bacteria

Anaeropharma Science Inc. (Tokyo, Japan) and Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) partnered to conduct joint research to discover cancer treatments using Anaeropharma's in situ Delivery and Production System (i-DPS) platform.

i-DPS modifies anaerobic bacteria Bifidobacterium longum to produce proteins to treat cancer. ...